2. Protein Energy Malnutrition
(PEM),
Protein-Energy Wasting
(PEW)
Kidney Disease Wasting
(KDW),
Kidney Disease-Related PEM
By
Mabrouk Ramadan Al-Sheikh
Prof. of nephrology and Internal Medicine
Faculty of Medicine
Tanta University
4. Eat right to feel and live right
Do not starve your patient
Let the food be the medicine and not let the
medicine be the food. “Hippocrates”
نعيش ال ،لنعيش نأكل نحنلنأكل
7. The International Society of Renal Nutrition
and Metabolism (ISRNM) expert panel
defined PEM (2012):
“state of decreased body stores of protein
and energy fuels i.e. body protein and fat
masses”
Definition
8. Definition
Component of PEM are
1. Clinical manifestations: unintentional poor
nutritional intake, unintentional BW loss,
depleted energy (fat tissues) stores, and loss
of somatic protein (low muscle mass).
2. Laboratory investigations: low level of
visceral protein; s. albumin, prealbumin and
transferrin and others.
3. Abnormal anthropometric measurements.
11. Prevalence
Depending in part upon the method used and the
population studied, up to 40 to 70 % of patients with
end-stage renal disease are malnourished.
17. Factors contributing to malnutrition
Malnutrition can be secondary to :
1- Poor nutritional intake:
Overzealous dietary restrictions.
Delayed gastric emptying and diarrhea.
Intercurrent illness .
Hospitalization.
Other medical cormorbidities.
18. Factors contributing to malnutrition
Malnutrition can be secondary to :
1- Poor nutritional intake
Medication causing dyspepsia e.g. phos. binders, iron therapy .
Suppression of oral intake by PD load.
Inadequate dialysis
Decreased food intake on HD days
Monetary restriction
Depression
Altered taste sensation
19. 2- Increased protein losses
Gastrointestinal blood loss:
“100ml blood = 14-17g protein.”
Intradialysis nitrogen loss:
“ HD : 6-8 g amino acid/ procedure”
“PD : 8-12 g protein/day”
Factors contributing to malnutrition
20. 3- Increased protein catabolism
Intercurrent illness and hospitalizations.
Metabolic acidosis.
Catabolism associated with HD
Catabolic effects of hormones “cortisol,
PTH, glucagon”
Dysfunction of GH and IGF endocrine axis.
Factors contributing to malnutrition
21. Squeals of PEM
Malaise, fatigue, poor rehabilitation
Increase susceptibility to infection.
Impaired wound healing.
Increase hospitalization rate.
Increase morbidity and mortality rate.
23. ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
24.
25. ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
26. I-Nutritional Intake
A- Patient’s interview
• Often provides important clue to patients who
might be malnurished
• Symptoms: nausea, vomiting, anorexia, fatigue,
weight loss or gain
• Pharmacological therapy: steroid therapy, iron
therapy and phos. binder
• Co-morbidity and non uremic diseases e.g. DM,
alcoholism, GI diseases.
• Psychological issues.
27. I-Nutritional Intake
Physical Examination
Should include anthropometry
The patient's actual BW is estimated and should be
compared to the recommended “dry or peer” body
weight.
The percentile change (if any) of the "dry weight"
should also be assessed approximately every month.
28. I-Nutritional Intake
B- Assessment of food intake
• Food questionnaire: the 24 h recall helps the patients to
remember food intake in the previous day and to
quantate it.
• Food record: quantitative and qualitative data on food
intake collected for an average 3 days including 2 two
week day and one week end day (3 days should include
dialysis and non-dialysis day).
• A food diary is very useful, especially if the patient
weighs the portions of food. The intake of protein, fat
and carbohydrate can then be calculated from standard
food tables.
29. I-Nutritional Intake
B- Assessment of food intake:
The semi-quantitative food–frequency questionnaire
(SFFQ): is used to assess the frequency of
consumption of food items and groups during a
specific reference time period, which may or may not
be the period the patient actually bases his(her)
recalls on.
30. I-Nutritional Intake
C-Protein equivalent of total nitrogen
appearance (PNA) & nPNA
Calculating the protein catabolic rate (PCR)
is a good indirect index for dietary
protein intake, expressed g/day.
KDOQI guidelines prefers the name:
protein equivalent of total nitrogen
appearance (PNA), expressed g/day.
Normalized nPNA ,expressed g/Kg/day.
31. I-Nutritional Intake
C-Protein equivalent of total nitrogen
appearance (PNA) & nPNA
Determination of nPNA: Calculated by
Formula Computer Program
Target level =1.0-1.2 g/Kg/day.
Best survival rate at level= 1.0-1.4 g/Kg/day.
An increased overall mortality rate at level
<0.8 or>1.4 g/Kg/day.
32. Interpretation of nPNA
Observation Interpretation Consideration
nPNA exceeds DPI
or is unexpectedly
high
Only tentative
conclusions about
protein intake possible
Catabolic state:
-Inadequate energy intake
-Presence of inflammation or inflammatory
stressors (fever, infection)
-Weight loss
- Metabolic acidosis
-Bioincompatible dialysis membrane.
Inaccurate diet record
Low lean body mass
nPNA less than
DPI or is
unexpectedly low
Only tentative
conclusions about
protein intake possible
Anabolic state:
-Corticosteroid use
- Recovery from infection or illness
- Pregnancy or growth
Inaccurate diet record
Edema or excess body weight
nPNA=DPI nPNA reflects protein
intake
Conclude patient is in nitrogen balance and
nPNA reflects intake if none of the above
apply
33. ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
34. II- Body composition
1- Body weight-based measures: BMI, weight for
height, edema-free BW, fat-free BW.
2- Skin and muscle anthropometry:
caliper, skin fold, extremity muscle mass.
3- Total body elements: total body potassium.
4- Energy-beam-based methods: total body N2,
DEXA, BIA, NIR.
5- Other method: underwater weighting.
35. A-BMI
The international classification of adult underweight, overweight and obesity
according to BMI
Classification BMI (kg/m2)
Underweight < 18.5
Severe thinness < 16
Moderate thinness 16-16.99
Mild thinness 17-18.49
Normal average 18.5-24.99
Overweight ≥ 25
Pre-obese 25-29.99
Obese ≥ 30
Obese class I 30-34.99
Obese class II 35-39.99
Obese class III ≥ 40
36. B-Anthropometry
Aim: to compare peer (ideal or average) BW to
the actual BW (special tables).
Anthropometry is practical, simple, rapid,
non-invasive, non-expensive and reproducible
technique for evaluating body fat and muscle
mass.
It can be easily done by dietitian.
37. B-Anthropometry
K/DOQI guidelines :
The anthropometric measurement that are valid for
assessing nutritional status:
1. For body fat : triceps (or biceps) skin fold(TSF) .
2. For muscle mass : mid arm muscle circumference
(MAMC) &mid arm circumference (MAC).
3. For obesity : BMI
4. % of usual body weight (UBW) and % of standard
body weight (SBW).
This measures should be taken immediately post-dialysis
at right side of the body; best carried out by the same
observer
38. As a general rule, the percentile values/normal
limitation to the use of anthropometry is that serial
measurements are best carried out by the same
observer
adequate nutritionValues >95 %
risk of malnutritionvalues 75 % and 95 %
significant
malnutrition
values <75 %
39. More sophisticated measures of body composition
include :
Bioelectric impedance analysis (BIA)
Dual-energy x-ray absorptiometry (DEXA)
A major drawback of these techniques is the
difficulty in distinguishing between fat mass and body
water.
40. At present, anthropometry is the only
method that can be readily performed in most
units.
BIA or DEXA should be reserved for selected
patients.
41. ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
42. III-Laboratory evaluation
1. Visceral protein: negative acute phase reactants;
albumin, prealbumin, transferrin and amino
acids.
2. Lipids: chlosterol, TG and other lipids.
3. Somatic protein and nitrogen surrogates: BUN
and serum creatinine.
4. Growth factors: IGF-1 and liptin.
5. Peripheral CBC, lymphocyts.
6. Others.
45. I-Plasma protein measurements
Serum Albumin
Clinical practice guidelines for nutrition were
published by a working group for the NKF/DOQI
recommended that the serum albumin
concentration (obtained either predialysis or
when stable) should be measured monthly.
46. I-Plasma protein measurements
Serum Albumin
Impact of Low serum albumin level:
It is strong predictor of mortality and
hospitalization; risk rises dramatically and
logarithmically as levels decline below 4.0
g/dL.
It has been shown to predict coronary
calcification.
47.
48. I-Plasma protein measurements
Serum transferrin:
Serum transferrin is not good indicator of nutritional
status; perhaps due to fluctuations in iron stores,
presence of inflammation and changes in volume
status.
49. I-Plasma protein measurements
Prealbumin
The plasma concentration of prealbumin (has a
shorter half-life than albumin) provides a consistent
assessment of visceral protein and can be used to
assess the response to nutritional interventions
begun for presumed malnutrition as it.
This protein is normally excreted and metabolized by
the kidney and tends to accumulate in renal failure.
51. I-Plasma protein measurements
Amino acids
There is a variable plasma amino acid pattern
in ESRD.
In general, the levels of the essential and
branched chain AA are decreased, while the
nonessential AA are either within the normal
range or increased.
52. III-Laboratory evaluation
II-Plasma cholesterol concentration
The plasma cholesterol concentration is reduced
in malnourished patients with normal renal
function.
Cholesterol levels are also lower in patients with
ESRDs. In this setting, there is an inverse
relationship between mortality and the
cholesterol concentration.
53. III-Laboratory evaluation
III-Blood urea nitrogen
Reflects the balance between urea generation and
removal
Malnourished patients often show a gradual reduction in
BUN and become wasted.
Low levels commonly seen in dialyzed patients (well
dialyzed or inadequately dialyzed) with poor nutrition.
Low predialysis BUN levels have also been associated
with increased mortality.
It is for this reason, protein catabolic rate is monitored in
dialysis patients, since this parameter can estimate
protein intake in the stable patient.
54. III-Laboratory evaluation
IV-Creatinine production
Since creatinine is produced from
nonenzymatic creatine metabolism in skeletal
muscle, estimating the rate of creatinine
production has been used to assess lean body
mass in stable patients.
Estimated lean body mass was below normal
in 47 and 66 % of hemodialysis and peritoneal
dialysis patients, a presumed reflection of
inadequate nutrition.
55. III-Laboratory evaluation
V- C-Reactive protein
A positive acute phase reactant protein.
It correlates negatively with visceral protein
concentration.
Help to uncover potential covert
inflammation especially if serum level of
albumin or prealbumin is low.
56. ASSESSMENT OF NUTRITIONAL STATUS
No gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
57. Subjective global assessment (SGA)
• Conventional SGA is a simple method depends
on the experience of clinician to make an
overall evaluation of nutritional status.
• Advantages: includes objective data and
several manifestations of poor nutritional
status.
• Limitation: heavy reliance on the clinical
judgment and the inability to tailor a specific
nutritional therapy.
58. Subjective global assessment (SGA)
This is a clinical method for evaluation of
nutritional status; including:-
A- History and symptoms:
1- % of weight loss in the last 6 months
2- Dietary nutrient intake
3- Presence of anorexia, nausea, vomiting, diarrhea
or abdominal pain
4- Functional capacity
5- Metabolic demands in the view of activity
59. Subjective global assessment (SGA)
B-Physical parameters focus on:
• Assessment of subcutanous fat.
• Assessment of muscle wasting in the temporal
area, deltoid and quadriceps.
• Presence of sacral or ankle odema.
• Presence of ascites.
63. Indices of malnutrition in HD patients
1. S. albumin concentration < 4.0 gm/dl.
2. Low s.prealbumin concentration (<30 mg/ dl)
3. Low b. urea & s. creatinine level in patients
with residual renal function.
4. PCR < 0.8gm/Kg/day.
5. Chol. concentration<150mg/dl(3.9mmol/L).
6. Transferrin <150 mg/dl.
64. Indices of malnutrition in HD patients
7. IGF-1 concentration < 300 µg/L.
8. Low predialysis serum K (and possibly
phosphororus) concentration.
9. Marked reduction in anthropometric
measurement
10. Continuous decline in estimated dry weight.
11. BW < 80% of ideal weight.
65.
66. Agenda
• Definition
• Factors contributing to malnutrition
• Disorders of nutrient metabolism in CKD
• Nutritional assessment
• Nutritional therapy
• Conclusion and Recommendations
67. Nutritional therapy
Why malnutrition should be corrected?
Many studies documented that poor
nutritional status increases the morbidity and
mortality CKD patients.
Specifically; low s. creatinine ,albumin
concentration and % of ideal dry BW at time
of initiation of maintenance dialysis are
associated with increased risk of morbidity
and mortality during sub sequent years of HD.
68. Why malnutrition should be corrected?
PEM is one of the strongest predictors of
mortality and morbidity and is the third of the
killing triad in CKD and HD patients
1.CV accidents
2.Infection
3.PEM
Nutritional therapy
69. Interventions to prevent and/or treat malnutrition
in advanced kidney failure
CKD patients:
1- Close supervision and nutritional counseling (especially for patients on protein-
restricted diets).
2- Initiation of dialysis or kidney transplant in advanced CKD patients with
apparent uremic malnutrition despite vigorous attempts to rectify it.
Maintenance dialysis patients:
1- Appropriate amount of dietary protein (> 1.2 g/kg/day) and calorie (> 35
kcal/kg/day) intake.
2- Optimal dose of dialysis (urea reduction ratio > 70%).
Use of biocompatible hemodialysis membranes.
3-Nutritional support in chronic dialysis patients who are unable to meet their
dietary needs:
a-Oral supplements.
b-Tube feeds (if medically appropriate).
c-Intradialytic parenteral nutritional supplements for HD patients.
d-Amino acid dialysate for peritoneal dialysis patients.
e-TPN
70. Nutritional therapy
Strategies for correction of malnutrition
I. Dietary counseling, support and optimization.
II. Adequate dialysis.
III. Nutritional support in chronic HD patient who
are unable to meet their dietary needs:
1- Oral supplementation.
2- Tube feeding(if medically appropriate).
3- IDPN supplements for HD patients.
4- AA dialysate for PD patients.
5-Continuos total parenteral nutrition(TPN)
71. Nutritional therapy
Other interventions
1. Correction of anemia, metabolic acidosis and
SHPT.
2. Anabolic agents :insulin, growth factor, or
androgenic anabolic steroid.
3. Exercise.
4. Treatment of inflammation :statin, vit E.
5. Social work.
6. Pharmacy support.
7. Transplantation.
72. Nutritional therapy
Dietary requirement
The recommended average level of nutritional
intake are listed in the following table.
These recommendations are consistent with
NKF ,KDOQI and EBP guidelines for nutrition
for CKD patient.
75. Nutritional therapy
Needs for individualization
Adherence to the renal diet is difficult & stressful.
Prescribed diet should be individualized to help every
patient in the terms of: cost, palatability,
comorbidities and cultural eating habits.
Too many restriction should be avoided as they may
lead to poor intake.
Reinforcement by all members of the family and
medical stuff.
Compliance should be assessed on regular basis even
monthly .
77. Adequacy of dialysis
Early referral to dialysis is very crucial.
Optimal dose of dialysis(URR>70%).
Use of biocompatible HD membrane.
Keep KT/V =1-1.2
An important consensus:
Adequate dialysis coupled with good
nutrition is the main pillar for best quality of life.
Adequate dialysis corrects uremia & anorexia
which enhance nutrition.
78. Peer rather than actual BW
Protein and caloric recommendation should
be based on the peer BW for healthy subjects
of the same age, sex, height and body frame
size as the patients.
80. Recommendation
• Understanding and application of the nutritional
principles.
• Periodic assessment of nutritional status (once/
month) should be part of the routine care of CKD and
dialysis patients to permit early recognition.
• Providing and institution of appropriate therapy for
the best improvement of nutrition status .
• Renal dietitian should be a member of the medical
personals.
81. Take home message
• PEM is underappreciated, although it largely
preventable and completely curable.
96. Response to reduced dietary protein and
energy intake.
• (A) Normal response. Reduced dietary protein and energy drive an
increase in hunger and
• a fall in REE, loss of protein preferentially from the visceral organs,
and increased insulin sensitivity of muscle.The liver and kidney
provide glucose, and serum albumin is maintained at a normal level.
• (B) Response with PEW. During PEW, the adaptations to increase
hunger and lower REE are blunted in part by an increased half-life of
leptin and ghrelin and in part by inflammation and dialysis. The loss
of protein occurs preferentially from muscle because of the effects of
metabolic acidosis, glucocorticoids, and inflammation, leading to
increased insulin resistance. Dialysis results in the loss of amino
acids, stimulating muscle protein breakdown. Under the influence of
inflammation and metabolic acidosis, the liver makes glutamine for
deamination in the kidney, increases acute-phase reactants, and
reduces serum albumin. The kidney increases glucose production
from glutamine under the influence of metabolic acidosis.
97. Potential causes of frailty and protein-energy wasting
in elderly patients with end stage kidney disease.
98.
99.
100.
101. Clinical consequences of frailty and protein-energy
wasting in elderly patients with end stage kidney
disease.
112. Selected nutritional parameters for varying
levels of kidney disease (K/DOQI guidelines)
Nutritional
Parameters
Stages 1-4 CKD Stage 5
Hemodialysis
Calories (kcal/kg/d) 30 – 35 35 - 60
Protein (g/kg/d) 0.6 – 0.75 1.2
Fat (% total kcal) For patients at risk for CVD, < 10%
saturated fat, 250-300 mg cholesterol/d
Sodium (g/d) < 2 2
Potassium (g/d) Match to laboratory
values
2 - 3
Calcium (g/d) 1.2 2 from diet and
medicines
Phosphorus (mg/d) Match to laboratory
values
800 – 1000
Fluid (ml/d) Unrestricted with
normal urine output
1000 + urine
Notas do Editor
PEW is the result
of multiple mechanisms inherent to CKD, including
undernutrition, systemic inflammation,
comorbidities, hormonal derangements, the dialysis
procedure, and other consequences of uremic toxicity.
PEW may cause infection, CVD, frailty, and
depression, but these complications may also
increase the extent of PEW.
(A) Normal response. Reduced dietary
protein and energy drive an increase in hunger and
a fall in REE, loss of protein preferentially from the visceral
organs, and increased insulin sensitivity of muscle.
The liver and kidney provide glucose, and serum
albumin is maintained at a normal level.
(B) Response
with PEW. During PEW, the adaptations to increase
hunger and lower REE are blunted in part by an increased
half-life of leptin and ghrelin and in part by inflammation
and dialysis. The loss of protein occurs
preferentially from muscle because of the effects of
metabolic acidosis, glucocorticoids, and inflammation,
leading to increased insulin resistance. Dialysis
results in the loss of amino acids, stimulating muscle
protein breakdown. Under the influence of inflammation
and metabolic acidosis, the liver makes glutamine
for deamination in the kidney, increases
acute-phase reactants, and reduces serum albumin.
The kidney increases glucose production from glutamine
under the influence of metabolic acidosis.
Suggested algorithm for clinical assessment and interventions aimed at assessing and treating PEW by manipulating protein intake in patients
with chronic kidney disease. 1Measured with bromcresol green method. 2Head-to-head comparisons of the different supplementation methods for the
treatment of PEW are not available. Individual patient characteristics and tolerance of, adherence to, and affordability of specific supplementation
methods should be considered. 3Efficacy and safety because treatment of PEW is not proven. 4Ideal amount of daily protein intake in PEW is unclear.
5Directed by specific clinical scenario. The efficacy and safety of PEW treatment in patients with non-dialysis-dependent chronic kidney disease is generally
unproven. DEI, daily energy intake; DPI, dietary protein intake; EAA, essential amino acid; eDPI, estimated daily protein intake; KA, keto acid; LPD, lowprotein
diet; PEW, protein-energy wasting; RAAS, renin angiotensin aldosterone system.